Author | Jonathan M. Meyer, MD

Articles

The Metabolic Syndrome and Schizophrenia: Clinical Research Update

February 01, 2007

The Metabolic Syndrome and Schizophrenia: Clinical Research Update

Glucose Dysregulation

March 01, 2003

The atypical antipsychotics have become the treatment of choice for patients with psychotic and other behavioral disorders. However, case reports, retrospective studies and epidemiological data suggest that these medications may be associated with new-onset type 2 diabetes and diabetic ketoacidosis.